Your browser doesn't support javascript.
loading
Risk profiling of patients with relapsed/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA.
Herrera, Alex F; Tracy, Samuel; Croft, Brandon; Opat, Stephen; Ray, Jill; Lovejoy, Alex F; Musick, Lisa; Paulson, Joseph N; Sehn, Laurie H; Jiang, Yanwen.
Afiliação
  • Herrera AF; City of Hope, Duarte, CA.
  • Tracy S; Genentech, Inc., South San Francisco, CA.
  • Croft B; Genentech, Inc., South San Francisco, CA.
  • Opat S; Clinical Haematology, Monash Health and Monash University, Clayton, Australia.
  • Ray J; Genentech, Inc., South San Francisco, CA.
  • Lovejoy AF; Roche Sequencing Solutions, Pleasanton, CA; and.
  • Musick L; Genentech, Inc., South San Francisco, CA.
  • Paulson JN; Genentech, Inc., South San Francisco, CA.
  • Sehn LH; British Columbia (BC) Cancer Centre for Lymphoid Cancer and the University of British Columbia, Vancouver, Canada.
  • Jiang Y; Genentech, Inc., South San Francisco, CA.
Blood Adv ; 6(6): 1651-1660, 2022 03 22.
Article em En | MEDLINE | ID: mdl-35086141

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / DNA Tumoral Circulante Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / DNA Tumoral Circulante Idioma: En Ano de publicação: 2022 Tipo de documento: Article